Impact of COVID-19 outbreak on NHL (National Hockey League)
Summary Analysing the impact that COVID-19 has had on the business of the NHL.
Scope - This report looks to understand the impact COVID-19 has had on the business of NHL, tracking the impact the pandemic has had on sponsorship, media rights and the matches themselves. The aim of this report is to understand the commercial impact the virus has had on the league.
Reasons to Buy - Analysing the impact that COVID-19 has had on the business of the NHL.
Our reports have been used by over 10K customers, including:
Best foot forward: Revenue will likely rise as more healthcare providers stress the importance of preventive care Abstract Podiatrists in the US Over the five years to 2019, the Podiatrists industry has stepped in the right direction. Revenue growth has been supported by the aging US population and...
Strong arch: As the unemployment rate declines, the industry’s customer base will grow Abstract Eyebrow Services in the USOperators in this industry are primarily engaged in threading, waxing or otherwise servicing eyebrows. Hair and nail salons are not included in this industry. This report covers...
Stretch goals: Rising disposable incomes and an aging population will drive revenue growth Abstract Physical Therapists in the US Over the five years to 2019, the role of physical therapy in promoting health and wellness has increased, benefiting this industry. As the number of individuals aged 50 and...
Patient history: The industry will likely benefit from new-and-improved service capability advances Abstract Diagnostic & Medical Laboratories in the US Operators in the Diagnostic and Medical Laboratories industry are an integral part of patients’ medical evaluation and treatment. Laboratories are...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
Melanoma - Global Drug Forecast and Market Analysis to 2029
Melanoma of the skin is a serious and aggressive form of cancer originating from melanocytes, the pigment cells in skin, and can develop anywhere on the body.Although melanoma has high survivability, it remains a significant health...
An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, heart, and other organs. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional...
Healthy future: Despite the mounting likelihood of new regulation, industry revenue will likely grow Abstract Cryogenic Biobanking Services Since the landmark scientific achievement of human genome sequencing in 2003, the Cryogenic Biobanking Services industry is increasingly viewed as the link between...
Abstract Fleet Telematics Systems Procurement in the US This report is intended to assist buyers of fleet telematics systems. Fleet telematics systems are used to monitor, map and track vehicle fleets in the field. Digital maps and Global Positioning System (GPS) technology allow for real-time visualization...
Research And Development
Wholesale Price Index
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.